Here are relevant reports on : ai-in-arts-culture-market
-
Cell Culture Vessels Market by Product [Vessels (Roller Bottles, Flasks, Cell Factory, Multiwell Plates), Accessories], Application [mAbs, Vaccines, CGT], End User [Pharma Biotech, Academia], Region - Global Forecast to 2030
The cell culture vessels market, valued at US$4.86 billion in 2024, stood at US$5.10 billion in 2025 and is projected to advance at a resilient CAGR of 9.5% from 2025 to 2030, culminating in a forecasted valuation of US$8.03 billion by the end of the period. Growth in the global cell culture vessels market is tied to the expansion of biopharma manufacturing worldwide. Demand is rising for biologics such as monoclonal antibodies, vaccines, and recombinant proteins.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Health Ingredients Market by Type (Vitamins, Minerals, Probiotics starter culture, Prebiotics, Nutritional Lipids, Functional Carbohydrates, Plant and Fruit Extracts, Enzymes, Proteins), Application, Source, Function and Region - Global Forecast to 2027
The market for health ingredients is projected to reach USD 146.3 billion by 2027, it is projected to grow at a CAGR of 7.8% during the forecast period. The key players in this market include Archer Daniels Midland Company (ADM) (US), Associated British Foods PLC (UK), International Flavors & Fragrances Inc. (US), Kerry Group PLC (Ireland), DSM (Netherlands), BASF SE (Germany), Cargill Incorporated (US), Ingredion (US), Arla Foods (Denmark), Tate & Lyle (UK), Lonza (Switzerland), Royal FrieslandCampina N.V. (Netherlands), Glanbia PLC (Ireland), CHR Hansen Holdings A/S, (Denmark), and Probi (Sweden). Strategic partnerships were the dominant strategy adopted by the key players, followed by expansions and new product launches. These strategies have helped them to increase their presence in different regions and industrial segments.
- Published: February 2023
- Price: $ 4950
- TOC Available:
-
Single Use Assemblies Market by Product (Bag (2D, 3D), Filtration, Bottle, Mixing, Tubing Assemblies), Solution (Customized, Standard), Modality (mAbs, Vaccines, CGT), Application (Filtration, Cell Culture, Storage, Transfer) - Global Forecasts to 2029
The global single-use assemblies market, valued at US$2.52 billion in 2023, stood at US$2.63 billion in 2024 and is projected to advance at a resilient CAGR of 13.2% from 2024 to 2029, culminating in a forecasted valuation of US$4.89 billion by the end of the period. The single-use assemblies market is experiencing significant growth with technological advancements.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Cell Culture Market by Product [Consumables (Media, Sera, Reagents; Accessories), Equipment (Bioreactors, Centrifuges, Filters, Incubators, Freezers)], Type (mAbs, Vaccines, Other), End User (Biopharma, CMOs) - Global Forecast to 2031
The global biopharmaceutical cell culture market, valued at USD 11.63 billion in 2025, stood at USD 12.81 billion in 2026 and is projected to advance at a resilient CAGR of 13.8% from 2026 to 2031, culminating in a forecasted valuation of USD 24.47 billion by the end of the period. The report profiles key players, including Thermo Fisher Scientific (US), Danaher (US), Sartorius AG (Germany), Merck KGaA (Germany), Corning Incorporated (US), FUJIFILM Holdings Corporation (Japan), and Eppendorf SE (Germany).
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Track Etched Membrane Market by Product (Membrane Filter, Capsule & Cartridge Filter, Cell Culture Insert), Material (Polycarbonate, Polyimide), Application (Cell Biology, Microbiology, Analytical testing, Automotive), End User - Global Forecasts to 2023
The track etched membrane market is projected to reach USD 813.1 million by 2023, growing at a CAGR of 11.3%. Key players operating in the global track etched membrane are GE Healthcare (US), Danaher (US), Corning (US), Merck (Germany), it4ip (Belgium), Sterlitech (US), Oxyphen (Switzerland), Sarstedt (US), BRAND GMBH (Germany), Sartorius (Germany), SABEU (Germany), Zefon International (US), GVS (Italy), Thermo Fisher Scientific (US), Eaton (Ireland), Greiner Bio-One (Austria), MACHEREY-NAGEL (Germany), Avanti Lipids Polar (US), SKC (US), Advantec (Canada), Avestin (Canada), Scaffdex (Finland), and Graver Technologies (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Cell Culture Reagents Market by Type (Growth Factors, Supplements, Cell Dissociation Reagents, Buffers & Chemicals, Others), Application (mAbs, Vaccines, CGT), End User (Pharma Biotech, Diagnostic Labs, Academia, Others), Region - Global Forecast to 2030
The cell culture reagents Market, valued at US$4.70 billion in 2024, stood at US$5.06 billion in 2025 and is projected to advance at a resilient CAGR of 12.1% from 2025 to 2030, culminating in a forecasted valuation of US$8.95 billion by the end of the period. The expansion of the global cell culture reagents market is primarily attributed to the global increase in biopharma manufacturing.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Middle East Cell Culture Market by Product (Consumables (Media, Sera, Reagents, Vessels (Roller Bottle, Flask, Cell Factory)), Equipment (Bioreactors, Centrifuges, Filtration, Incubators, Freezers)), Application (mAbs, Vaccines, CGT), & End User - Forecast to 2031
The Middle East cell culture market, valued at USD 0.51 billion in 2025, stood at USD 0.54 billion in 2026 and is projected to advance at a resilient CAGR of 9.1% from 2026 to 2031, culminating in a forecasted valuation of USD 0.83 billion by the end of the period.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
North America Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The North America Cell Culture Market, valued at US$11.10 billion in 2024, stood at US$11.86 billion in 2025 and is projected to advance at a resilient CAGR of 11.4% from 2025 to 2030, culminating in a forecasted valuation of US$20.38 billion by the end of the period. Growth of the North America cell culture market is driven by a strong and expanding biopharmaceutical industry, with rising production of biologics such as monoclonal antibodies, vaccines, and cell-based therapies that rely heavily on advanced culture techniques and systems.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Europe Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The Europe Cell Culture Market, valued at US$8.01 billion in 2024, stood at US$8.50 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$14.23 billion by the end of the period. The growth of the Europe cell culture market is driven by a strong and expanding biopharmaceutical sector, with rising production of biologics such as monoclonal antibodies, vaccines, and recombinant proteins that rely on sophisticated culture systems.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Aquaculture Products Market by Rearing Product Type (Equipment, Chemicals, Pharmaceuticals, Fertilizers), Culture (Freshwater, Marine, Brackish Water), Species (Aquatic Animals, Aquatic Plants), Production Type and Region - Global Forecast to 2027
The global aquaculture products market projected to reach USD 56.2 billion by 2027, recording a CAGR of 7.2% during the forecast period. The key players in this market include Pentair PLC (US), AKVA Group (Norway), Xylem Inc. (US), Aquaculture Equipment Ltd (UK), and Aquaculture System Technologies LLC (US).
- Published: February 2023
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
